For research use only. Not for therapeutic Use.
Cadisegliatin(Cat No.:I043416)is an investigational small molecule used in the treatment of type 2 diabetes. It works by inhibiting the enzyme glucokinase regulatory protein (GKRP), which regulates the activity of glucokinase, an enzyme involved in glucose metabolism. By enhancing glucokinase activity, Cadisegliatin helps improve glucose uptake and insulin sensitivity in the liver, thereby lowering blood glucose levels. Its mechanism offers a novel approach to managing diabetes, with potential benefits in controlling hyperglycemia without the weight gain or hypoglycemia associated with some other diabetes treatments. Cadisegliatin is under investigation in clinical trials for safety and efficacy.
CAS Number | 859525-02-3 |
Synonyms | 2-[[2-[[cyclohexyl-(4-propoxycyclohexyl)carbamoyl]amino]-1,3-thiazol-5-yl]sulfanyl]acetic acid |
Molecular Formula | C21H33N3O4S2 |
Purity | ≥95% |
IUPAC Name | 2-[[2-[[cyclohexyl-(4-propoxycyclohexyl)carbamoyl]amino]-1,3-thiazol-5-yl]sulfanyl]acetic acid |
InChI | InChI=1S/C21H33N3O4S2/c1-2-12-28-17-10-8-16(9-11-17)24(15-6-4-3-5-7-15)21(27)23-20-22-13-19(30-20)29-14-18(25)26/h13,15-17H,2-12,14H2,1H3,(H,25,26)(H,22,23,27) |
InChIKey | HPGJSAAUJGAMLV-UHFFFAOYSA-N |
SMILES | CCCOC1CCC(CC1)N(C2CCCCC2)C(=O)NC3=NC=C(S3)SCC(=O)O |
Chemistry Calculators | Dilution Calculator In vivo Formulation Calculator Molarity Calculator Molecular Weight Calculator Reconstitution Calculator |